Is the development of clinical practice guidelines for non‐neurogenic overactive bladder trustworthy? A critical appraisal using the Appraisal of Guidelines, Research and Evaluation (AGREE) II instrument

Bravo‐Balado, Alejandra; Plata, Mauricio; Trujillo, Carlos Gustavo; Caicedo, Juan Ignacio; Serrano, Aylen Vanessa Ospina; Ramos, Anamaria; Cataño, Juan Guillermo

doi:10.1111/bju.14684

Cited by 7 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To establish our threshold, a literature review of articles using the AGREE-II tool was performed. Reviews implementing this instrument established an arbitrary threshold of >70% to determine high-quality guidelines (51)(52)(53). As such, we used this published threshold to define high quality.…”

Section: Agree-ii Domainmentioning

confidence: 99%

Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II

et al. 2022

View full text Add to dashboard Cite

IntroductionSince its approval for adults with moderate-to-severe atopic dermatitis (AD) in 2017, dupilumab has been incorporated into clinical practice guidelines (CPGs). However, recommendations differ internationally, and the quality assessment of their development is unclear.ObjectiveWe aimed to systematically review and appraise the quality of CPGs for adult AD reported since 2017 and map the recommendations for dupilumab initiation relative to conventional systemic therapy (CST).Materials and MethodsA literature search was conducted in June 2020 in MEDLINE, EMBASE, SCOPUS, and CINAHL. Twelve CPGs were retrieved. Methodological quality was assessed using the validated Appraisal of Guidelines for Research & Evaluation II tool (AGREE-II). Recommendations were extracted and compared.ResultsAGREE-II median scores per domain of the CPGs were (%, r = range): scope/purpose, 78% (50–96); stakeholder involvement, 54% (28–85); rigor of development, 39% (21–63); clarity of presentation, 85% (69–100); applicability, 27% (6–51); and editorial independence, 76% (42–100). Neither met the threshold of 70% quality criteria for rigor of development nor the applicability domains. Three CPGs met the criteria for recommendation without modification. CPGs' approach to dupilumab initiation was as follows: second line, preferred over CST and nbUVB (n = 1/12 CPG); second line, equivalent to CST or nbUVB (n = 3/12 CPGs); third line, after nbUVB or CST (n = 5/12 CPGs); and fourth line after nbUVB and CST (n = 2/12). No consensus was reached for n = 1/12 CPG.Conclusion and RelevanceDupilumab is now incorporated into CPGs for adult AD. These CPGs exhibited good quality in scope/purpose, clarity, and editorial independence domains. However, none met AGREE-II criteria for methodological rigor/applicability. Gaps were found in mechanisms for updates, facilitators/barriers, resource implications, and stakeholder involvement. Only n = 3/12 CPGs met quality criteria for recommendation without modifications. Of these, two favored a conservative sequential approach for the initiation of dupilumab relative to CST, while one did not reach consensus. Our findings highlight divergent recommendations AD treatment, underlining a need to incorporate quality criteria into future guideline development.

show abstract

Section: Agree-ii Domainmentioning

confidence: 99%

Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Two studies have tried to answer the question. Hoffmann-Esser et al 13 conducted an online survey of 58 German-speaking guideline appraisers and guideline users, asking them to indicate the "potential influence of the [23] AGREE II items on the two overall assessments (overall guideline quality and recommendation for use)" by rating the "strength of the influence on a Likert scale (0 = no influence to 5 = very strong influence)." (The AGREE II Manual indicates that in making the two global assessments, scores on the 23 items and six domains should be considered, but the two should not be calculated from them.…”

Section: What Is Newmentioning

confidence: 99%

What Determines the Quality of Rehabilitation Clinical Practice Guidelines?

Dijkers

Ward

Annaswamy

et al. 2020

Am J Phys Med Rehabil

View full text Add to dashboard Cite

show abstract

“…Various practice management guidelines have been developed to guide decision-making (Heyns & Rienhardt 2002 ; NICE 2013 ; Vaz et al 2019 ). The NICE ( 2013 ) guideline scored 97% on the Appraisal of Guidelines for Research and Evaluation score compared to other guidelines (Bravo-Balado et al 2019 ) and is recommended for use. The South African guideline for UI management was developed in 2002 and did not include current evidence (Heyns & Rienhardt 2002 ).…”

Section: Introductionmentioning

confidence: 99%

Practitioner’s knowledge, attitudes, beliefs and practices towards urinary incontinence

Janse van Vuuren,

van Rensburg,

Hanekom

2023

South African Journal of Physiotherapy

View full text Add to dashboard Cite

Background: One in three women in South Africa suffer from urinary incontinence. Effective management is influenced by patients help-seeking behaviour and services offered by healthcare professionals within the healthcare system. Current practice towards urinary incontinence management in South Africa is unknown.Objectives: Our study aimed to describe and compare urinary incontinence practice and knowledge of nurses and physicians (practitioners) working in primary healthcare settings, measured against the NICE 2013 guideline and explore attitudes and beliefs towards urinary incontinence management.Method: Cross-sectional study using a self-designed online questionnaire. All primary healthcare practitioners in the Western Cape were eligible for the study. Stratified random and snowball sampling was used. Data was analysed in consultation with a statistician using SPSS.Results: Fifty-six completed questionnaires were analysed. Practitioners had an overall knowledge score of 66.7% and practice score of 68.9% compared to NICE 2013 guidelines. A lack of knowledge regarding urinary incontinence screening, following up on patients and conducting bladder diaries were noted. Pelvic floor muscle training and bladder training education was recognised as initial management but only 14.8% of practitioners referred patients to physiotherapy. Half of the sample reported being uncomfortable with urinary incontinence, although the majority wanted to learn more about urinary incontinence.Conclusion: The knowledge and practices of practitioners working at a primary healthcare level in the Western Cape are not congruent with NICE 2013 guidelines.Clinical implications: Data can be used to inform intervention planning to address urinary incontinence management at a primary healthcare level in the Western Cape.

show abstract

Is the development of clinical practice guidelines for non‐neurogenic overactive bladder trustworthy? A critical appraisal using the Appraisal of Guidelines, Research and Evaluation (AGREE) II instrument

Cited by 7 publications

References 6 publications

Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II

Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II

What Determines the Quality of Rehabilitation Clinical Practice Guidelines?

Practitioner’s knowledge, attitudes, beliefs and practices towards urinary incontinence

Contact Info

Product

Resources

About